BIODESIX INC BDSX
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2020-10-28
BIODESIX INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| PATIENCE JOHN | director | 2026-03-31 | Option exercise | 1,361 | — |
| Pestano Gary Anthony | Chief Development Officer | 2026-02-23 | Sell | 556 | $12.78 |
| Vazquez Chris | Chief Accounting Officer | 2026-02-23 | Sell | 211 | $12.78 |
| O'Kane Kieran | Chief Commercial Officer | 2026-02-23 | Sell | 535 | $12.78 |
| Hutton Scott | President & CEO | 2026-02-23 | Sell | 1,490 | $12.78 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | 2026-02-23 | Sell | 535 | $12.78 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer | 2026-02-20 | Option exercise | 1,469 | — |
| Vazquez Chris | Chief Accounting Officer | 2026-02-20 | Option exercise | 563 | — |
Source: SEC EDGAR filings · CIK 0001439725 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.